Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harrow (HROW) Gains from Investment Securities: 2013-2025

Historic Gains from Investment Securities for Harrow (HROW) over the last 7 years, with Mar 2025 value amounting to $38,000.

  • Harrow's Gains from Investment Securities fell 89.92% to $38,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $1.5 million, marking a year-over-year decrease of 5.22%. This contributed to the annual value of $327,831 for FY2024, which is 155.77% up from last year.
  • According to the latest figures from Q1 2025, Harrow's Gains from Investment Securities is $38,000, which was down 98.67% from $2.9 million recorded in Q3 2024.
  • Harrow's 5-year Gains from Investment Securities high stood at $2.9 million for Q3 2024, and its period low was -$1.8 million during Q2 2023.
  • Moreover, its 3-year median value for Gains from Investment Securities was $128,174 (2023), whereas its average is $493,514.
  • As far as peak fluctuations go, Harrow's Gains from Investment Securities soared by 175,100.00% in 2021, and later crashed by 257.55% in 2023.
  • Over the past 5 years, Harrow's Gains from Investment Securities (Quarterly) stood at -$1.7 million in 2021, then crashed by 34.25% to $1.2 million in 2022, then tumbled by 257.55% to $128,174 in 2023, then spiked by 5,142.17% to $2.9 million in 2024, then crashed by 89.92% to $38,000 in 2025.
  • Its Gains from Investment Securities stands at $38,000 for Q1 2025, versus $2.9 million for Q3 2024 and $377,000 for Q1 2024.